Go Back

Articles

1. Abdel-Wahab, M., S. Grover, E.H. Zubizarreta, and J.A. Polo Rubio, Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives. Brachytherapy, 2020. 19(6): p. 850-856, link.

2. Anacak, Y., E. Zubizarreta, M. Zaghloul, S. Laskar, J. Alert, S. Gondhowiardjo, A. Giselvania, R. Correa-Villar, F. Pedrosa, B. Dorj, S. Kamer, S.C. Howard, Y. Quintana, R.C. Ribeiro, E. Rosenblatt, and K. Hopkins, The Practice of Paediatric Radiation Oncology in Low- and Middle-income Countries: Outcomes of an International Atomic Energy Agency Study. Clin Oncol (R Coll Radiol), 2020, link.

3. Calvo, F.A., B.S. Chera, E. Zubizarreta, P. Scalliet, R.R. Prasad, A. Quarneti, K. Akbarov, and M. Abdel-Wahab, The role of the radiation oncologist in quality and patient safety: A proposal of indicators and metrics. Crit Rev Oncol Hematol, 2020. 154: p. 103045, link.

4. Chan, J., J. Friborg, E. Zubizarreta, J.W. van Eck, T.P. Hanna, J.M. Bourque, M. Gaudet, K. Dennis, R. Olson, C.N. Coleman, A.J. Petersen, C. Grau, M. Abdel-Wahab, M. Brundage, B. Slotman, and A. Polo, Examining geographic accessibility to radiotherapy in Canada and Greenland for indigenous populations: Measuring inequities to inform solutions. Radiother Oncol, 2020. 146: p. 1-8, link.

5. Griffin, R.J., M.M. Ahmed, B. Amendola, O. Belyakov, S.M. Bentzen, K.T. Butterworth, S. Chang, C.N. Coleman, V. Djonov, S.C. Formenti, E. Glatstein, C. Guha, S. Kalnicki, Q.T. Le, B.W. Loo, Jr., A. Mahadevan, M. Massaccesi, P.G. Maxim, M. Mohiuddin, M. Mohiuddin, N.A. Mayr, C. Obcemea, K. Petersson, W. Regine, M. Roach, P. Romanelli, C.B. Simone, 2nd, J.W. Snider, D.R. Spitz, B. Vikram, M.C. Vozenin, M. Abdel-Wahab, J. Welsh, X. Wu, and C.L. Limoli, Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation Therapy. Int J Radiat Oncol Biol Phys, 2020. 107(4): p. 766-778, link.

6. Mir, R., S.M. Kelly, Y. Xiao, A. Moore, C.H. Clark, E. Clementel, C. Corning, M. Ebert, P. Hoskin, C.W. Hurkmans, S. Ishikura, I. Kristensen, S.F. Kry, J. Lehmann, J.M. Michalski, A.F. Monti, M. Nakamura, K. Thompson, H. Yang, E. Zubizarreta, N. Andratschke, and E. Miles, Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines. Radiother Oncol, 2020. 150: p. 30-39, link.

7. Vinnikov, V., M.P. Hande, R. Wilkins, A. Wojcik, E. Zubizarreta, and O. Belyakov, Prediction of the Acute or Late Radiation Toxicity Effects in Radiotherapy Patients Using Ex Vivo Induced Biodosimetric Markers: A Review. J Pers Med, 2020. 10(4), link.

8. Vinnikov, V.A. and O. Belyakov, Radiation Exposure Biomarkers in the Practice of Medical Radiology: Cooperative Research and the Role of the International Atomic Energy Agency (IAEA) Biodosimetry/Radiobiology Laboratory. Health Phys, 2020. 119(1): p. 83-94, link.

9. Abdel-Wahab, M., A. Nitzsche-Bell, A. Olson, A. Polo, M.M. Shah, E. Zubizarreta, and S. Patel, Radiation Oncology in Global Health, in Radiology in global health : strategies, implementation, and applications, D.J. Mollura, M.P. Culp, and M.P. Lungren, Editors. 2019, Springer Science+Business Media: New York, NY. p. 349-360.

10. Chan, J., A. Polo, E. Zubizarreta, J.M. Bourque, T.P. Hanna, M. Gaudet, K. Dennis, M. Brundage, B. Slotman, and M. Abdel-Wahab, Access to radiotherapy and its association with cancer outcomes in a high-income country: Addressing the inequity in Canada. Radiother Oncol, 2019. 141: p. 48-55, link.

11. Chopra, S., P. Mittal, A. Viswanathan, E. Tharavichitkul, E. Zubizarreta, R.A. Nout, M.L. Yap, S. Grover, D. Rodin, B. Rai, S. Gondhowiardjo, and S.K. Shrivastava, Global Collaborations for Cervical Cancer: Can the East-West Alliance Facilitate Treatment for all? Clin Oncol (R Coll Radiol), 2019. 31(8): p. 529-538, link.

12. Cordero-Méndez, L., E. Zubizarreta, Y. Pynda, and M. Abdel-Wahab, Global cancer control: The role of the International Atomic Energy Agency and future perspectives Cancer Control 2019: p. 53-57, link.

13. Elmore, S.N.C., G.B. Prajogi, J.A.P. Rubio, and E. Zubizarreta, The global radiation oncology workforce in 2030: Estimating physician training needs and proposing solutions to scale up capacity. Appl Rad Oncol, 2019. 8(2): p. 10-16, link.

14. Hoskin, P.J., K. Hopkins, V. Misra, T. Holt, R. McMenemin, D. Dubois, F. McKinna, B. Foran, K. Madhavan, C. MacGregor, A. Bates, N. O'Rourke, J.F. Lester, T. Sevitt, D. Roos, S. Dixit, G. Brown, S. Arnott, S.S. Thomas, S. Forsyth, S. Beare, K. Reczko, A. Hackshaw, and A. Lopes, Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial. JAMA, 2019. 322(21): p. 2084-2094, link.

15. Mahantshetty, U.M., Scale-up of radiotherapy for cervical cancer. Lancet Oncol, 2019. 20(7): p. 888-889, link.

16. Rodin, D., E.A. Burger, R. Atun, M. Barton, M. Gospodarowicz, S. Grover, T.P. Hanna, D.A. Jaffray, F.M. Knaul, Y. Lievens, E. Zubizarreta, and M. Milosevic, Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact. Lancet Oncol, 2019. 20(7): p. 915-923, link.

17. Vinnikov, V. and O. Belyakov, Clinical Applications of Biomarkers of Radiation Exposure: Limitations and Possible Solutions through Coordinated Research. Radiat Prot Dosimetry, 2019. 186(1): p. 3-8, link.

18. Autsavapromporn, N., P. Klunklin, C. Threeratana, W. Tuntiwechapikul, M. Hosoda, and S. Tokonami, Short Telomere Length as a Biomarker Risk of Lung Cancer Development Induced by High Radon Levels: A Pilot Study. Int J Environ Res Public Health, 2018. 15(10), link.

19. Coffey, M. and E. Rosenblatt, Guest short communication: Is education of RTTs really unnecessary? Technical Innovations & Patient Support in Radiation Oncology, 2018. 8: p. 1-2, link.

22. Izewska, J., M. Coffey, P. Scalliet, E. Zubizarreta, T. Santos, I. Vouldis, and P. Dunscombe, Improving the quality of radiation oncology: 10years' experience of QUATRO audits in the IAEA Europe Region. Radiother Oncol, 2018. 126(2): p. 183-190, link.

23. Jacinto, A.A., E.S. Batalha Filho, L.S. Viana, P. De Marchi, R.C. Capuzzo, R.R. Gama, D. Boldrini Junior, C.R. Santos, G.D.J. Pinto, J.M. Dias, H.P. Canton, R. Carvalho, L.A. Radicchi, S. Bentzen, E. Zubizarreta, and A.L. Carvalho, Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma. BMC Cancer, 2018. 18(1): p. 1026, link.

24. Pistenmaa, D.A., M. Dosanjh, U. Amaldi, D. Jaffray, E. Zubizarreta, K. Holt, Y. Lievens, Y. Pipman, and C.N. Coleman, Changing the global radiation therapy paradigm. Radiother Oncol, 2018. 128(3): p. 393-399, link.

25. Rosenblatt, E., The known roots of a known problem. Gynecol Oncol Rep, 2018. 25: p. 109, link.

26. Rosenblatt, E., E. Fidarova, S. Ghosh, E. Zubizarreta, O. Unterkirhere, N. Semikoz, V. Sinaika, V. Kim, N. Karamyan, and I. Isayev, Quality of radiotherapy services in post-Soviet countries: An IAEA survey. Radiotherapy and Oncology, 2018, link.

28. Rosenblatt, E., R.R. Prasad, K. Hopkins, A. Polo, N. Ndlovu, M.S. Zaghloul, G. Paris, and L. Kochbati, Africa Radiation Oncology Network (AFRONET): an IAEA Telemedicine Pilot Project. Journal of the International Society for Telemedicine and EHealth, 2018. 6(1): p. 1-7, link.

30. Abdel-Wahab, M., B. Lahoupe, A. Polo, E. Zubizarreta, R.R. Adnan, P. Johnston, A. Juric, F.E. Haffar, M. Andre, and A. Meghzifene, Assessment of cancer control capacity and readiness: the role of the International Atomic Energy Agency. Lancet Oncol, 2017. 18(10): p. e587-e594, link.

31. Abdel-Wahab, M., E. Zubizarreta, A. Polo, and A. Meghzifene, Improving Quality and Access to Radiation Therapy-An IAEA Perspective. Semin Radiat Oncol, 2017. 27(2): p. 109-117, link.

32. Barton, M.B., E. Zubizarreta, and M. Gospodarowicz, Radiotherapy in Low- and Middle-income Countries. What Can We Do Differently? Clin Oncol (R Coll Radiol), 2017. 29(2): p. 69-71, link.

33. Barton, M.B., E.H. Zubizarreta, and J.A. Polo Rubio, Radiotherapy in small countries. Cancer Epidemiol, 2017. 50(Pt B): p. 257-259, link.

34. Guedes de Castro, D., J. Matiello, W. Roa, S. Ghosh, L. Kepka, N. Kumar, V. Sinaika, D. Lomidze, D. Hentati, E. Rosenblatt, and E. Fidarova, Survival Outcomes With Short-Course Radiation Therapy in Elderly Patients With Glioblastoma: Data From a Randomized Phase 3 Trial. Int J Radiat Oncol Biol Phys, 2017. 98(4): p. 931-938, link.

35. Lievens, Y., M. Gospodarowicz, S. Grover, D. Jaffray, D. Rodin, J. Torode, M.L. Yap, E. Zubizarreta, G. Steering, and Advisory Committees, Global impact of radiotherapy in oncology: Saving one million lives by 2035. Radiother Oncol, 2017. 125(2): p. 175-177, link.

36. Nongrum, S., S.T. Vaiphei, J. Keppen, M. Ksoo, E. Kashyap, and R.N. Sharan, Identification and Preliminary Validation of Radiation Response Protein(s) in Human Blood for a High-throughput Molecular Biodosimetry Technology for the Future. Genome Integr, 2017. 8(1): p. 5, link.

37. Parkes, J., C. Hess, H. Burger, Y. Anacak, V. Ahern, S.C. Howard, M. Elhassan, S. Ahmed, M. Ghalibafian, A.N. Abbasi, B.M. Qureshi, M. Zaghloul, E. Zubizarreta, P. Bey, A. Davidson, E. Bouffet, and N. Esiashvili, Recommendations for the treatment of children with radiotherapy in low- and middle-income countries (LMIC): A position paper from the Pediatric Radiation Oncology Society (PROS-LMIC) and Pediatric Oncology in Developing Countries (PODC) working groups of the International Society of Pediatric Oncology (SIOP). Pediatr Blood Cancer, 2017. 64 Suppl 5(Suppl 5): p. S1-S11, link.

38. Rosenblatt, E., G.B. Prajogi, M. Barton, E. Fidarova, J.G. Eriksen, B. Haffty, B.A. Millar, A. Bustam, E. Zubizarreta, and M. Abdel-Wahab, Need for Competency-Based Radiation Oncology Education in Developing Countries. Creative Education, 2017. 08(01): p. 66-80, link.

39. van der Merwe, D., J. Van Dyk, B. Healy, E. Zubizarreta, J. Izewska, B. Mijnheer, and A. Meghzifene, Accuracy requirements and uncertainties in radiotherapy: a report of the International Atomic Energy Agency. Acta Oncol, 2017. 56(1): p. 1-6, link.

40. Van Dyk, J., E. Zubizarreta, and Y. Lievens, Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven activity-based analysis. Radiother Oncol, 2017. 125(2): p. 178-185, link.

41. Vinnikov, V.A., Optimizing the Microscopy Time Schedule for Chromosomal Dosimetry of High-dose and Partial-body Irradiations. Genome Integr, 2017. 8(1): p. 3, link.

42. Zeegers, D., S. Venkatesan, S.W. Koh, G.K. Low, P. Srivastava, N. Sundaram, S. Sethu, B. Banerjee, M. Jayapal, O. Belyakov, R. Baskar, A.S. Balajee, and M.P. Hande, Biomarkers of Ionizing Radiation Exposure: A Multiparametric Approach. Genome Integr, 2017. 8(1): p. 6, link.

43. Zubizarreta, E., J. Van Dyk, and Y. Lievens, Analysis of Global Radiotherapy Needs and Costs by Geographic Region and Income Level. Clin Oncol (R Coll Radiol), 2017. 29(2): p. 84-92, link.

44. Fidarova, E., L. Kepka, V. Sinaika, N. Kumar, J. Matiello, D. Lomidze, K. Dyttus-Cebulok, and D. Dinakaran, 9: Quality of Life in Elderly/Frail Patients with Glioblastoma Multiforme: Results of a Randomized Phase III Study Comparing Short and Standard Course of Radiotherapy. Radiotherapy and Oncology, 2016. 120: p. S4, link.

46. Izewska, J., M. Coffey, P. Scalliet, E. Zubizarreta, T. Santos, I. Vouldis, and P. Dunscombe, Lessons from the findings of 31 QUATRO audits in Europe. Radiotherapy and Oncology, 2016. 119(Suppl. 1): p. 922-922, link.

47. Konert, T., W.V. Vogel, S. Everitt, M.P. MacManus, D. Thorwarth, E. Fidarova, D. Paez, J.J. Sonke, and G.G. Hanna, Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocol. Radiother Oncol, 2016. 121(1): p. 39-45, link.

48. Lam, K.O., A.W. Lee, C.W. Choi, H.C. Sze, A.L. Zietman, K.I. Hopkins, and E. Rosenblatt, Global Pattern of Nasopharyngeal Cancer: Correlation of Outcome With Access to Radiation Therapy. Int J Radiat Oncol Biol Phys, 2016. 94(5): p. 1106-12, link.

49. Lam, K.O., A.W. Lee, W.T. Ng, and K.I. Hopkins, The International Atomic Energy Agency global initiatives on nasopharyngeal cancer treatment. Chin Clin Oncol, 2016. 5(2): p. 27, link.

50. Rosenblatt, E., A. Meghzifene, O. Belyakov, and M. Abdel-Wahab, Relevance of Particle Therapy to Developing Countries. Int J Radiat Oncol Biol Phys, 2016. 95(1): p. 25-9, link.

51. Socha, J., L. Kepka, S. Ghosh, W. Roa, N. Kumar, V. Sinaika, J. Matiello, D. Lomidze, D.G. de Castro, D. Hentati, and E. Fidarova, Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients. J Neurooncol, 2016. 126(3): p. 493-8, link.

52. Yap, M.L., E. Zubizarreta, F. Bray, J. Ferlay, and M. Barton, Global Access to Radiotherapy Services: Have We Made Progress During the Past Decade? J Glob Oncol, 2016. 2(4): p. 207-215, link.

53. Atun, R., D.A. Jaffray, M.B. Barton, F. Bray, M. Baumann, B. Vikram, T.P. Hanna, F.M. Knaul, Y. Lievens, T.Y. Lui, M. Milosevic, B. O'Sullivan, D.L. Rodin, E. Rosenblatt, J. Van Dyk, M.L. Yap, E. Zubizarreta, and M. Gospodarowicz, Expanding global access to radiotherapy. Lancet Oncol, 2015. 16(10): p. 1153-86, link.

54. Hassan Metwally, M.A., R. Ali, M. Kuddu, T. Shouman, P. Strojan, K. Iqbal, R. Prasad, C. Grau, and J. Overgaard, IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma. Radiother Oncol, 2015. 116(1): p. 15-20, link.

55. Hoskin, P., A. Rojas, E. Fidarova, R. Jalali, A. Mena Merino, A. Poitevin, S. Oucrif, S. Abdelwahab, L. Kochbati, A. Plieskiene, F. Casas, S. Stojanovic, G. Schneider, and B. Jeremic, IAEA randomised trial of optimal single dose radiotherapy in the treatment of painful bone metastases. Radiother Oncol, 2015. 116(1): p. 10-4, link.

56. Jaffray, D.A., R. Atun, M. Barton, M. Baumann, M. Gospodarowicz, P. Hoskin, F.M. Knaul, Y. Lievens, E. Rosenblatt, J. Torode, J. Van Dyk, B. Vikram, and Union for International Cancer Control's Global Task Force on Radiotherapy for Cancer Control, Radiation therapy and the global health agenda. Clin Oncol (R Coll Radiol), 2015. 27(2): p. 67-9, link.

57. Jaffray, D.A., F.M. Knaul, R. Atun, C. Adams, M.B. Barton, M. Baumann, Y. Lievens, T.Y. Lui, D.L. Rodin, E. Rosenblatt, J. Torode, J. Van Dyk, B. Vikram, and M. Gospodarowicz, Global Task Force on Radiotherapy for Cancer Control. Lancet Oncol, 2015. 16(10): p. 1144-6, link.

58. Jeremic, B., E. Fidarova, V. Sharma, M. Faheem, A.A. Ameira, C. Nasr Ben Ammar, A. Frobe, F. Lau, S. Brincat, and G. Jones, The International Atomic Energy Agency (IAEA) randomized trial of palliative treatment of incurable locally advanced non small cell lung cancer (NSCLC) using radiotherapy (RT) and chemotherapy (CHT) in limited resource setting. Radiother Oncol, 2015. 116(1): p. 21-6, link.

59. Kirisits, C., M. Federico, K. Nkiwane, E. Fidarova, I. Jurgenliemk-Schulz, A. de Leeuw, J. Lindegaard, R. Potter, and K. Tanderup, Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run. Radiother Oncol, 2015. 117(3): p. 548-54, link.

60. Konert, T., W. Vogel, M.P. MacManus, U. Nestle, J. Belderbos, V. Gregoire, D. Thorwarth, E. Fidarova, D. Paez, A. Chiti, and G.G. Hanna, PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014. Radiother Oncol, 2015. 116(1): p. 27-34, link.

61. Rosenblatt, E., O. Acuna, and M. Abdel-Wahab, The challenge of global radiation therapy: an IAEA perspective. Int J Radiat Oncol Biol Phys, 2015. 91(4): p. 687-9, link.

62. Rosenblatt, E., M. Barton, W. Mackillop, E. Fidarova, L. Cordero, J. Yarney, G. Lim, A. Abad, V. Cernea, S. Stojanovic-Rundic, P. Strojan, L. Kobachi, and A. Quarneti, Optimal radiotherapy utilisation rate in developing countries: An IAEA study. Radiother Oncol, 2015. 116(1): p. 35-7, link.

63. Rosenblatt, E., E. Zubizarreta, J. Izewska, S. Binia, F. Garcia-Yip, and P. Jimenez, Quality audits of radiotherapy centres in Latin America: a pilot experience of the International Atomic Energy Agency. Radiat Oncol, 2015. 10: p. 169, link.

64. Zubizarreta, E.H., E. Fidarova, B. Healy, and E. Rosenblatt, Need for radiotherapy in low and middle income countries - the silent crisis continues. Clin Oncol (R Coll Radiol), 2015. 27(2): p. 107-14, link.

65. Chen, Y., P.K. Zhou, X.Q. Zhang, Z.D. Wang, Y. Wang, and F. Darroudi, Cytogenetic studies for a group of people living in Japan 1 year after the Fukushima nuclear accident. Radiat Prot Dosimetry, 2014. 159(1-4): p. 20-5, link.

66. Faulkner, C., A. Palmer, H. Williams, C. Wragg, H.R. Haynes, P. White, R.M. DeSouza, M. Williams, K. Hopkins, and K.M. Kurian, EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers. Br J Neurosurg, 2014. 29(1): p. 1-7, link.

67. Kepka, L., W. Roa, N. Kumar, V. Sinaika, J. Matiello, D. Lomidze, D. Hentati, D.G. de Castro, S. Ghosh, and E. Fidarova, PD-0519: Short course vs. standard course radiotherapy, in elderly and/or fragile patients with glioblastoma multiforme. Radiotherapy and Oncology, 2014. 111: p. S204-S205, link.

69. Melidis, C., W.R. Bosch, J. Izewska, E. Fidarova, E. Zubizarreta, K. Ulin, S. Ishikura, D. Followill, J. Galvin, A. Haworth, D. Besuijen, C.H. Clark, E. Miles, E. Aird, D.C. Weber, C.W. Hurkmans, and D. Verellen, Global harmonization of quality assurance naming conventions in radiation therapy clinical trials. Int J Radiat Oncol Biol Phys, 2014. 90(5): p. 1242-9, link.

70. Menon, T., Y. Pynda, E. Rosenblatt, E. Zubizarreta, E. Fidarova, and G. Jones, A unique PDF-form/e-form manager platform to improve data quantity and quality in IAEA randomized trials. Research Gate, 2014, link.

72. Rosenblatt, E., Planning national radiotherapy services. Front Oncol, 2014. 4: p. 315, link.

73. Rosenblatt, E., M. Abdel-Wahab, M. El-Gantiry, I. Elattar, J.M. Bourque, M. Afiane, N. Benjaafar, S. Abubaker, Y. Chansilpa, B. Vikram, and P. Levendag, Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency. Radiat Oncol, 2014. 9: p. 67, link.

74. Vaiphei, S.T., J. Keppen, S. Nongrum, R. Chaubey, L. Kma, and R. Sharan, Evaluation of endogenous control gene (s) for gene expression studies in human blood exposed to 60 Co ?-rays ex vivo. Journal of radiation research, 2014. 56(1): p. 177-185, link.

75. Wang, Z., H. Hu, M. Hu, X. Zhang, Q. Wang, Y. Qiao, H. Liu, L. Shen, P. Zhou, and Y. Chen, Ratio of gamma-H2AX level in lymphocytes to that in granulocytes detected using flow cytometry as a potential biodosimeter for radiation exposure. Radiat Environ Biophys, 2014. 53(2): p. 283-90, link.

76. Weller, M., M. van den Bent, K. Hopkins, J.C. Tonn, R. Stupp, A. Falini, E. Cohen-Jonathan-Moyal, D. Frappaz, R. Henriksson, C. Balana, O. Chinot, Z. Ram, G. Reifenberger, R. Soffietti, W. Wick, and European Association for Neuro-Oncology Task Force on Malignant Glioma, EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol, 2014. 15(9): p. e395-403, link.

77. Abdel-Wahab, M., J.M. Bourque, Y. Pynda, J. Izewska, D. Van der Merwe, E. Zubizarreta, and E. Rosenblatt, Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol, 2013. 14(4): p. e168-75, link.

78. Deatsch-Kratochvil, A.N., T.N. Pascual, A. Kesner, E. Rosenblatt, and R.K. Chhem, The International Atomic Energy Agency's activities in radiation medicine and cancer: promoting global health through diplomacy. Can Assoc Radiol J, 2013. 64(1): p. 2-5, link.

79. Goss, P.E., B.L. Lee, T. Badovinac-Crnjevic, K. Strasser-Weippl, Y. Chavarri-Guerra, J. St Louis, C. Villarreal-Garza, K. Unger-Saldana, M. Ferreyra, M. Debiasi, P.E. Liedke, D. Touya, G. Werutsky, M. Higgins, L. Fan, C. Vasconcelos, E. Cazap, C. Vallejos, A. Mohar, F. Knaul, H. Arreola, R. Batura, S. Luciani, R. Sullivan, D. Finkelstein, S. Simon, C. Barrios, R. Kightlinger, A. Gelrud, V. Bychkovsky, G. Lopes, S. Stefani, M. Blaya, F.H. Souza, F.S. Santos, A. Kaemmerer, E. de Azambuja, A.F. Zorilla, R. Murillo, J. Jeronimo, V. Tsu, A. Carvalho, C.F. Gil, C. Sternberg, A. Duenas-Gonzalez, D. Sgroi, M. Cuello, R. Fresco, R.M. Reis, G. Masera, R. Gabus, R. Ribeiro, R. Knust, G. Ismael, E. Rosenblatt, B. Roth, L. Villa, A.L. Solares, M.X. Leon, I. Torres-Vigil, A. Covarrubias-Gomez, A. Hernandez, M. Bertolino, G. Schwartsmann, S. Santillana, F. Esteva, L. Fein, M. Mano, H. Gomez, M. Hurlbert, A. Durstine, and G. Azenha, Planning cancer control in Latin America and the Caribbean. Lancet Oncol, 2013. 14(5): p. 391-436, link.

80. Hellebust, T.P., K. Tanderup, C. Lervag, E. Fidarova, D. Berger, E. Malinen, R. Potter, and P. Petric, Dosimetric impact of interobserver variability in MRI-based delineation for cervical cancer brachytherapy. Radiother Oncol, 2013. 107(1): p. 13-9, link.

81. Kadhim, M., S. Salomaa, E. Wright, G. Hildebrandt, O.V. Belyakov, K.M. Prise, and M.P. Little, Non-targeted effects of ionising radiation--implications for low dose risk. Mutat Res, 2013. 752(2): p. 84-98, link.

82. Levendag, P.C., F. Keskin-Cambay, C. de Pan, M. Idzes, M.A. Wildeman, I. Noever, I.K. Kolkman-Deurloo, A. Al-Mamgani, M. El-Gantiry, E. Rosenblatt, and D.N. Teguh, Local control in advanced cancer of the nasopharynx: is a boost dose by endocavitary brachytherapy of prognostic significance? Brachytherapy, 2013. 12(1): p. 84-9, link.

83. Myint, P., J. Wondergem, Y. Pynda, and G.O. Phillips, An international survey of tissue banking: a preliminary report. Cell Tissue Bank, 2013. 14(2): p. 159-65, link.

84. Petric, P., R. Hudej, P. Rogelj, M. Blas, K. Tanderup, E. Fidarova, C. Kirisits, D. Berger, J.C. Dimopoulos, R. Potter, and T.P. Hellebust, Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study. Radiother Oncol, 2013. 107(1): p. 6-12, link.

85. Prasad, R.R. and P. Singh, Report of chronic myeloid leukemia from Indira Gandhi Institute of Medical Sciences, Regional Cancer Center, 2002-2009. Indian J Med Paediatr Oncol, 2013. 34(3): p. 172-4, link.

86. Rosenblatt, E., J. Izewska, Y. Anacak, Y. Pynda, P. Scalliet, M. Boniol, and P. Autier, Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database. Lancet Oncol, 2013. 14(2): p. e79-86, link.

87. Schmid, M.P., E. Fidarova, R. Potter, P. Petric, V. Bauer, V. Woehs, P. Georg, K. Kirchheiner, D. Berger, C. Kirisits, W. Dorr, and J.C. Dimopoulos, Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy. Acta Oncol, 2013. 52(7): p. 1384-90, link.

88. Schmid, M.P., B. Mansmann, M. Federico, J.C. Dimopoulous, P. Georg, E. Fidarova, W. Dorr, and R. Potter, Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. A low-field MRI study. Strahlenther Onkol, 2013. 189(3): p. 238-44, link.

89. Vinnikov, V.A. and N.A. Maznyk, Cytogenetic dose-response in vitro for biological dosimetry after exposure to high doses of gamma-rays. Radiat Prot Dosimetry, 2013. 154(2): p. 186-97, link.

90. Wondergem, J., M. Boerma, K. Kodama, F.A. Stewart, and K.R. Trott, Cardiovascular effects after low-dose exposure and radiotherapy: what research is needed? Radiat Environ Biophys, 2013. 52(4): p. 425-34, link.

91. Dimopoulos, J.C., M.P. Schmid, E. Fidarova, D. Berger, C. Kirisits, and R. Potter, Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. Int J Radiat Oncol Biol Phys, 2012. 82(5): p. 1880-8, link.

92. Fidarova, E., E. Zubizarreta, J. Wondergem, I. Stojkovski, and E. Rosenblatt, 101 BRACHYTHERAPY: THE IAEA VISION AND POLICY. Radiotherapy and Oncology, 2012. 103: p. S39-S40, link.

94. Miralbell, R., S.A. Roberts, E. Zubizarreta, and J.H. Hendry, Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: alpha/beta = 1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys, 2012. 82(1): p. e17-24, link.

95. Rosenblatt, E., B.G. Haffty, and J.W. Leer, Assessing Clinical Competence in Radiation Oncology Education, in Radiology Education. 2012, Springer, Berlin, Heidelberg: Berlin, Heidelberg. p. 117-128, link.

97. Wondergem, J. and E. Rosenblatt, IAEA activities related to radiation biology and health effects of radiation. J Radiol Prot, 2012. 32(1): p. N123-7, link.

98. Yip, C.H., M. Samiei, E. Cazap, E. Rosenblatt, N.R. Datta, R. Camacho, D. Weller, S. Pannarunothai, C. Goh, F. Black, R. Kaur, M. Fitch, C. Sutcliffe, S. Sutcliffe, and Iccc- Working Group, Coordinating care and treatment for cancer patients. Asian Pac J Cancer Prev, 2012. 13(4 Suppl): p. 23-36, link.

99. Abdel-Wahab, M., E. Rosenblatt, O. Holmberg, and A. Meghzifene, Safety in radiation oncology: the role of international initiatives by the International Atomic Energy Agency. J Am Coll Radiol, 2011. 8(11): p. 789-94, link.

100. Salminen, E.K., K. Kiel, G.S. Ibbott, M.C. Joiner, E. Rosenblatt, E. Zubizarreta, J. Wondergem, and A. Meghzifene, International Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting. Radiat Oncol, 2011. 6(1): p. 11, link.

101. Jeremic, B., F. Casas, L. Wang, and B. Perin, Radiochemotherapy in extensive disease small cell lung cancer ED-SCLC. Front Radiat Ther Oncol, 2010. 42: p. 180-6, link.

102. Jeremic, B., F. Casas, L. Wang, and B. Perin, Radiation therapy for early stage (I/II) non-small cell lung cancer. Front Radiat Ther Oncol, 2010. 42: p. 87-93, link.

103. Kesner, A., M. Dondi, A. Meghzifene, D. Paez, E. Zubizarreta, S. Palm, F. Mut, J. Wondergem, and R. Chhem, IAEA’s human health professional resource website. 2010, Journal of Nuclear Medicine. p. 1056-1056, link.

105. Rosenblatt, E., G. Jones, R.K. Sur, B. Donde, J.V. Salvajoli, S. Ghosh-Laskar, A. Frobe, A. Suleiman, Z. Xiao, and S. Nag, Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiother Oncol, 2010. 97(3): p. 488-94, link.

106. Sharma, V., P.M. Gaye, S.A. Wahab, N. Ndlovu, T. Ngoma, V. Vanderpuye, A. Sowuhami, D.A. Dawotola, J. Kigula-Mugambe, and B. Jeremic, Palliative radiation therapy practice for advanced esophageal carcinoma in Africa. Dis Esophagus, 2010. 23(3): p. 240-3, link.

107. Zimmermann, F., J. Wulf, I. Lax, Y. Nagata, R.D. Timmerman, I. Stojkovski, and B. Jeremic, Stereotactic body radiation therapy for early non-small cell lung cancer. Front Radiat Ther Oncol, 2010. 42: p. 94-114, link.

108. Belderbos, J.S., L. Kepka, F.M. Kong, M.K. Martel, G.M. Videtic, and B. Jeremic, Elective nodal irradiation (ENI) in locally advanced non-small-cell lung cancer (NSCLC): evidence versus opinion? Int J Radiat Oncol Biol Phys, 2009. 74(1): p. 322; author reply 322-3, link.

109. Casas, F., L. Kepka, J.P. Agarwal, D. Dawotola, P. Gaye, S. Abdel-Wahab, L. Vashkevitch, T. Saghatelyan, B. Perin, and B. Jeremic, Radiochemotherapy in the elderly with lung cancer. Expert Rev Anticancer Ther, 2009. 9(10): p. 1405-11, link.

110. Frobe, A., G. Jones, B. Jaksic, T. Bokulic, M. Budanec, M. Iva, D. Stancic-Rokotov, D. Hrabar, A. Bolanca, E. Rosenblatt, and Z. Kusic, Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus. Dis Esophagus, 2009. 22(6): p. 513-8, link.

111. Gay, H.A., C.H. Sibata, R.R. Allison, and B. Jeremic, Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy. Radiother Oncol, 2009. 91(3): p. 369-78, link.

112. Hendry, J.H., S.L. Simon, A. Wojcik, M. Sohrabi, W. Burkart, E. Cardis, D. Laurier, M. Tirmarche, and I. Hayata, Human exposure to high natural background radiation: what can it teach us about radiation risks? J Radiol Prot, 2009. 29(2A): p. A29-42, link.

113. Jeremic, B., Radiochemotherapy in lung cancer: from reality to reality. Expert Rev Anticancer Ther, 2009. 9(10): p. 1349-51, link.

114. Jeremic, B., Activities in the field of lung cancer coordinated by the section of applied radiation biology And Radiotherapy of the International Atomic Energy Agency. J Thorac Oncol, 2009. 4(8): p. 941-2, link.

115. Jeremic, B. and P. Hoskin, Radiochemotherapy in common solid tumours--from developed to a developing world. Clin Oncol (R Coll Radiol), 2009. 21(7): p. 513-4, link.

116. Jeremic, B. and B. Milicic, Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol, 2009. 32(2): p. 163-8, link.

117. Jeremic, B. and B. Milicic, Pretreatment prognostic factors influencing distant metastasis-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol, 2009. 32(5): p. 483-7, link.

118. Kepka, L., F. Casas, B. Perin, S. Abdel-Wahab, T. Saghatelyan, L. Vashkevitch, P.M. Gaye, D. Dawotola, J.P. Agarwal, and B. Jeremic, Radiochemotherapy for lung cancer in developing countries. Clin Oncol (R Coll Radiol), 2009. 21(7): p. 536-42, link.

119. Kepka, L., A. Sprawka, F. Casas, S. Abdel-Wahab, J.P. Agarwal, and B. Jeremic, Combination of radiotherapy and chemotherapy in locally advanced NSCLC. Expert Rev Anticancer Ther, 2009. 9(10): p. 1389-403, link.

120. Kepka, L., A. Sprawka, F. Casas, S. Abdel-Wahab, J.P. Agarwal, and B. Jeremic, Radiochemotherapy in small-cell lung cancer. Expert Rev Anticancer Ther, 2009. 9(10): p. 1379-87, link.

121. MacManus, M., U. Nestle, K.E. Rosenzweig, I. Carrio, C. Messa, O. Belohlavek, M. Danna, T. Inoue, E. Deniaud-Alexandre, S. Schipani, N. Watanabe, M. Dondi, and B. Jeremic, Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006-2007. Radiotherapy and Oncology, 2009. 91(1): p. 85-94, link.

122. Roa, W., J.Z. Xing, C. Small, R. Kortmann, R. Miriamanoff, P. Okunieff, Y. Shibamoto, and B. Jeremic, Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme. Expert Rev Anticancer Ther, 2009. 9(11): p. 1643-50, link.

123. Salminen, E., Y. Anacak, S. Laskar, R.D. Kortmann, E. Raslawski, G. Stevens, and R.C. Ribeiro, Twinning partnerships through International Atomic Energy Agency (IAEA) to improve radiotherapy in common paediatric cancers in low- and mid-income countries. Radiother Oncol, 2009. 93(2): p. 368-71, link.

124. Belderbos, J.S., L. Kepka, M.K. Martel, G.M. Videtic, and B. Jeremic, Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: Non–small-cell lung cancer (NSCLC). International Journal of Radiation Oncology* Biology* Physics, 2008. 72(2): p. 335-342, link.

126. Hendry, J.H., M. Akahoshi, L.S. Wang, S.E. Lipshultz, F.A. Stewart, and K.R. Trott, Radiation-induced cardiovascular injury. Radiat Environ Biophys, 2008. 47(2): p. 189-93, link.

127. Jeremic, B. and C. Koning, Induction chemotherapy before chemoradiation in locally advanced non-small-cell lung cancer: failure after failure, again and again. J Clin Oncol, 2008. 26(10): p. e1-2, link.

128. Jeremic, B. and B. Milicic, Pretreatment prognostic factors of local recurrence-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol, 2008. 31(3): p. 213-8, link.

129. Jeremic, B. and B. Milicic, From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer. Cancer, 2008. 112(4): p. 876-84, link.

130. Jeremic, B. and B. Milicic, Influence of low-dose daily cisplatin on the distant metastasis-free survival of patients with locally advanced nonmetastatic head and neck cancer treated with radiation therapy. Radiother Oncol, 2008. 87(2): p. 201-3, link.

131. Sharma, V., Save time. Use efficiently what you have. Int.J.Rad.Oncol.Biol.Phys, 2008. 71(5): p. 1601, link.

134. Shortt, K., L. Davidsson, J. Hendry, M. Dondi, and P. Andreo, International perspectives on quality assurance and new techniques in radiation medicine: outcomes of an IAEA conference. Int J Radiat Oncol Biol Phys, 2008. 71(1 Suppl): p. S80-4, link.

135. Videtic, G.M., J.S. Belderbos, F.M. Spring Kong, L. Kepka, M.K. Martel, and B. Jeremic, Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: small-cell lung cancer (SCLC). Int J Radiat Oncol Biol Phys, 2008. 72(2): p. 327-34, link.

136. Wang, X., M.R. Allen, D.B. Burr, E.J. Lavernia, B. Jeremic, and D.P. Fyhrie, Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone. Bone, 2008. 43(4): p. 775-80, link.

137. Bese, N.S., J. Hendry, and B. Jeremic, Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys, 2007. 68(3): p. 654-61, link.

138. Davidson, S.E., A. Trotti, O.U. Ataman, J. Seong, F.N. Lau, N.W. da Motta, and B. Jeremic, Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys, 2007. 69(4): p. 1218-21, link.

139. Dobrowsky, W., N.G. Huigol, R.S. Jayatilake, N.I. Kizilbash, S. Okkan, V.T. Kagiya, and H. Tatsuzaki, AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial. Radiother Oncol, 2007. 82(1): p. 24-9, link.

140. Jeremic, B., Low incidence of isolated nodal failures after involved-field radiation therapy for non small-cell lung cancer: blinded by the light? J Clin Oncol, 2007. 25(35): p. 5543-5, link.

141. Jeremic, B. and B. Milicic, Influence of interfraction interval on local tumor control in patients with limited-disease small-cell lung cancer treated with radiochemotherapy. Int J Radiat Oncol Biol Phys, 2007. 68(2): p. 426-32, link.

142. Jeremic, B. and S. Pitz, Primary optic nerve sheath meningioma: stereotactic fractionated radiation therapy as an emerging treatment of choice. Cancer, 2007. 110(4): p. 714-22, link.

143. Kepka, L., V. Danilova, T. Saghatelyan, A. Bajcsay, O. Utehina, S. Stojanovic, D. Yalman, A. Demiral, O. Bondaruk, M. Kuddu, B. Jeremic, and International Atomic Energy Agency, Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey. Lung Cancer, 2007. 56(2): p. 235-45, link.

144. Macbeth, F.R., R.P. Abratt, K.H. Cho, R.J. Stephens, B. Jeremic, and International Atomic Energy Agency, Lung cancer management in limited resource settings: guidelines for appropriate good care. Radiother Oncol, 2007. 82(2): p. 123-31, link.

145. Stojkovski, I., M. Dondi, B. Jeremic, and P. Andreo, The role of IAEA in preparation of recommendations for the use of PET/CT in radiotherapy planning. Biomed Imaging Interv J, 2007. 3(1): p. e19, link.

146. Agarawal, J.P., T. Swangsilpa, Y. van der Linden, D. Rades, B. Jeremic, and P.J. Hoskin, The role of external beam radiotherapy in the management of bone metastases. Clin Oncol (R Coll Radiol), 2006. 18(10): p. 747-60, link.

147. Auperin, A., C. Le Pechoux, J.P. Pignon, C. Koning, B. Jeremic, G. Clamon, L. Einhorn, D. Ball, M.G. Trovo, H.J. Groen, J.A. Bonner, T. Le Chevalier, R. Arriagada, and Meta-Analysis of Cisplatin/carboplatin based Concomitant Chemotherapy in non-small cell Lung Cancer Group, Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. Ann Oncol, 2006. 17(3): p. 473-83, link.

148. Bese, N.S., K. Kiel, K. El-Gueddari Bel, O.B. Campbell, B. Awuah, B. Vikram, and International Atomic Energy Agency, Radiotherapy for breast cancer in countries with limited resources: program implementation and evidence-based recommendations. Breast J, 2006. 12 Suppl 1(Suppl 1): p. S96-102, link.

149. Chen, Y., A. Trotti, C.N. Coleman, M. Machtay, R.O. Mirimanoff, J. Hay, C. O'Brien P, B. El-Gueddari, J.V. Salvajoli, and B. Jeremic, Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation. Int J Radiat Oncol Biol Phys, 2006. 64(5): p. 1442-51, link.

150. Eniu, A., R.W. Carlson, Z. Aziz, J. Bines, G.N. Hortobagyi, N.S. Bese, R.R. Love, B. Vikram, A. Kurkure, B.O. Anderson, and Global Summit Treatment Allocation of Resources Panel, Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J, 2006. 12 Suppl 1: p. S38-53, link.

151. Hendry, J.H., B. Jeremic, and E.H. Zubizarreta, Normal tissue complications after radiation therapy. Rev Panam Salud Publica, 2006. 20(2-3): p. 151-60, link.

152. Horsman, M.R., L. Bohm, G.P. Margison, L. Milas, J.F. Rosier, G. Safrany, E. Selzer, M. Verheij, and J.H. Hendry, Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting. Int J Radiat Oncol Biol Phys, 2006. 64(2): p. 551-61, link.

153. Jeremic, B., Timing of concurrent radiotherapy and chemotherapy in limited-disease small-cell lung cancer: "Meta-analysis of meta-analyses". Int J Radiat Oncol Biol Phys, 2006. 64(4): p. 981-2, link.

154. Jeremic, B., B. Milicic, A. Dagovic, L. Acimovic, and S. Milisavljevic, Pretreatment prognostic factors in patients with early-stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone. Int J Radiat Oncol Biol Phys, 2006. 65(4): p. 1112-9, link.

155. San Jose, S., M.D. Arnaiz, A. Lucas, V. Navarro, G. Serrano, M. Zaderazjko, B. Jeremic, and F. Guedea, Radiation therapy alone in elderly with early stage non-small cell lung cancer. Lung Cancer, 2006. 52(2): p. 149-54, link.

156. Wambersie, A., J.H. Hendry, P. Andreo, P.M. DeLuca, R. Gahbauer, H. Menzel, and G. Whitmore, The RBE issues in ion-beam therapy: conclusions of a joint IAEA/ICRU working group regarding quantities and units. Radiat Prot Dosimetry, 2006. 122(1-4): p. 463-70, link.

157. Dobrowsky, W., N.G. Huigol, R.S. Jayatilake, N.I. Kizilbash, S. Okkan, T.V. Kagiya, and H. Tatsuzaki, AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cancer cervix: initial results of an IAEA multicentre randomized trial. J Cancer Res Ther, 2005. 1(2): p. 75-8, link.

158. Hendry, J.H., Protective effects on microorganisms in radiation sterilised tissues, in Sterilisation of Tissues Using Ionising Radiations. 2005, Elsevier. p. 331-338, link.

160. Vasanthan, A., M. Mitsumori, J.H. Park, Z. Zhi-Fan, Z. Yu-Bin, P. Oliynychenko, H. Tatsuzaki, Y. Tanaka, and M. Hiraoka, Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys, 2005. 61(1): p. 145-53, link.

161. West, C.M., M.J. McKay, T. Holscher, M. Baumann, I.J. Stratford, R.G. Bristow, M. Iwakawa, T. Imai, S.M. Zingde, M.S. Anscher, J. Bourhis, A.C. Begg, K. Haustermans, S.M. Bentzen, and J.H. Hendry, Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting. Int J Radiat Oncol Biol Phys, 2005. 62(5): p. 1264-73, link.

162. Kim, J.Y., C.H. Kim, I.J. Stratford, A.V. Patterson, and J.H. Hendry, The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell line. International Journal of Radiation Oncology Biology Physics, 2004. 58(2): p. 376-385, link.

163. Kim, J.Y., A.V. Patterson, I.J. Stratford, and J.H. Hendry, The importance of DT-diaphorase and hypoxia in the cytotoxicity of RH1 in human breast and non-small cell lung cancer cell lines. Anticancer Drugs, 2004. 15(1): p. 71-7, link.

164. Kim, J.Y., C.M. West, H. Valentine, T.H. Ward, A.V. Patterson, I.J. Stratford, S.A. Roberts, and J.H. Hendry, Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation. Radiother Oncol, 2004. 70(3): p. 311-7, link.

165. Roberts, S.A., J.H. Hendry, R. Swindell, J.M. Wilkinson, and R.D. Hunter, Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomised clinical trial. Radiother Oncol, 2004. 70(1): p. 63-74, link.

166. Sangar, V.K., R. Cowan, G.P. Margison, J.H. Hendry, and N.W. Clarke, An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines. Br J Cancer, 2004. 90(2): p. 542-8, link.

167. Sindermann, J.R., V. Verin, J.W. Hopewell, H.P. Rodemann, and J.H. Hendry, Biological aspects of radiation and drug-eluting stents for the prevention of restenosis. Cardiovasc Res, 2004. 63(1): p. 22-30, link.

168. Sur, R., B. Donde, C. Falkson, S.N. Ahmed, V. Levin, S. Nag, R. Wong, and G. Jones, Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. Brachytherapy, 2004. 3(4): p. 191-5, link.

169. Wambersie, A., J. Hendry, J. Gueulette, R. Gahbauer, R. Potter, and V. Gregoire, Radiobiological rationale and patient selection for high-LET radiation in cancer therapy. Radiother Oncol, 2004. 73 Suppl 2: p. S1-14, link.

170. Zubizarreta, E.H., A. Poitevin, and C.V. Levin, Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA). Radiother Oncol, 2004. 73(1): p. 97-100, link.

171. Burkart, W. and J. Hendry, From Hiroshima to Chernobyl: Epidemiological findings, uncertainties ans perceptions. Atw-Internationale Zeitschrift Fur Kernenergie, 2003. 48(4): p. 236-+, link.

172. Grau, C., J. Prakash Agarwal, K. Jabeen, A. Rab Khan, S. Abeyakoon, T. Hadjieva, I. Wahid, S. Turkan, H. Tatsuzaki, K.A. Dinshaw, and J. Overgaard, Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial. Radiother Oncol, 2003. 67(1): p. 17-26, link.

173. Huilgol, N.G., W. Dobrowsky, H. Tatsuzaki, N.A. Chatterjee, V.T. Kagiya, and K. Das, Sanazole as a sensitizer of hypoxic cells with radical radiation in the treatment of advanced cancer of cervix an Indian experience. Indian J Cancer, 2002. 39(2): p. 39-44, link.

174. Levin, V. and H. Tatsuzaki, Radiotherapy services in countries in transition: gross national income per capita as a significant factor. Radiother Oncol, 2002. 63(2): p. 147-50, link.

175. Nag, S., M. Dally, M. de la Torre, H. Tatsuzaki, N. Kizilbash, S. Kurusun, L. Pinillos, B. Pokrajac, R. Sur, and V. Levin, Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency. Radiother Oncol, 2002. 64(3): p. 297-308, link.

176. Sur, R.K., C.V. Levin, B. Donde, V. Sharma, L. Miszczyk, and S. Nag, Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys, 2002. 53(1): p. 127-33, link.

177. Sur, R.K., C.V. Levin, B. Donde, V. Sharma, L. Miszczyk, and S. Nag, Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma—an International Atomic Energy Agency study. International Journal of Radiation Oncology* Biology* Physics, 2002. 53(1): p. 127-133, link.

179. Ohara, K., H. Tatsuzaki, N.G. Molotkova, T. Oda, K. Yuzawa, Y. Saida, Y. Matsuzaki, W. Shimizu, T. Todoroki, K. Fukao, N. Tanaka, and Y. Itai, Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancer. Hepatogastroenterology, 2001. 48(39): p. 859-63, link.

180. Ohara, K., H. Tatsuzaki, W. Shimizu, S. Sugahara, N.G. Molotkova, and Y. Itai, Exfoliative tumor clearance following radiotherapy estimated by comparing radioresponse between primary esophageal cancer and its lymph node metastasis. Hepato-Gastroenterology, 2001. 48(42): p. 1648-1651, link.

181. Tatsuzaki, H. and C.V. Levin, Quantitative status of resources for radiation therapy in Asia and Pacific region. Radiother Oncol, 2001. 60(1): p. 81-9, link.

182. Yap, S.F., Y.C. Chen, G. Doraisamy, S. Jayaranee, M. Rosmawati, and K.L. Goh, Hepatitis C virus genotypes in peninsular Malaysia. Asia-Pacific Journal of Molecular Biology and Biotechnology, 1997. 5(2): p. 118-122, link.